Venous Thromboembolism Treatment Options Market, Global Outlook and Forecast 2024-2031

The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood's ability to clot. They don't break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.
This report contains market size and forecasts of Venous Thromboembolism Treatment Options in global, including the following market information:
Global Venous Thromboembolism Treatment Options Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Venous Thromboembolism Treatment Options Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Venous Thromboembolism Treatment Options companies in 2021 (%)
The global Venous Thromboembolism Treatment Options market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Upper Pneumatic Compression Sleeves Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Venous Thromboembolism Treatment Options include AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp. and Janssen Pharmaceuticals, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Venous Thromboembolism Treatment Options manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Venous Thromboembolism Treatment Options Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Venous Thromboembolism Treatment Options Market Segment Percentages, by Type, 2021 (%)
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Others
Global Venous Thromboembolism Treatment Options Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Venous Thromboembolism Treatment Options Market Segment Percentages, by Application, 2021 (%)
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers
Global Venous Thromboembolism Treatment Options Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Venous Thromboembolism Treatment Options Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Venous Thromboembolism Treatment Options revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Venous Thromboembolism Treatment Options revenues share in global market, 2021 (%)
Key companies Venous Thromboembolism Treatment Options sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Venous Thromboembolism Treatment Options sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc